Opti Capital Management »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Opti Capital Management

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Opti Capital Management from 13F filings

Historical chart of Opti Capital Management investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Opti Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Opti Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $33M 36M 0.94

More positions owned by Opti Capital Management

Insight Enterprises Note 0.750% 2/1
Royal Caribbean Group Note 6.000% 8/1
Unity Software Note 11/1
Novocure Note 11/0
Bentley Sys Note 0.125% 1/1
Blackline Note 3/1
Five9 Note 0.500% 6/0
Glaukos Corp Note 2.750% 6/1
Alarm Com Hldgs Note 1/1
Nuvasive Note 0.375% 3/1
Fastly Note 3/1
Omnicell Note 0.250% 9/1
Alnylam Pharmaceuticals Note 1.000% 9/1
Innoviva Note 2.500% 8/1
Alphatec Hldgs Note 0.750% 8/0

View all positions for Opti Capital Management

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ing Investment Management
Deerfield Management Company
Aequim Alternative Investments
Lazard Asset Management
BlackRock
Calamos Advisors
Invesco
MacKay Shields
Shenkman Capital Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Capstone Investment Advisors
SSI Investment Management
Bnp Paribas Arbitrage, Snc
Bank of America Corporation
Franklin Resources

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1